ITP and ITT

NHS England has established an Innovation and Technology Payment (ITP) and NHS Innovation Accelerator (NIA) Programme to fast track the introduction and adoption of innovations.

The ITP and NIA are intended to help reduce the difficulties experienced by innovators and clinicians in achieving uptake and spread of technologies and services across the NHS.


Innovation and Technology Payment and Innovation and Technology Tariff

The Innovation Technology Payment (ITP) and predecessor, the Innovation and Technology Tariff (ITT) removes financial or procurement barriers to the uptake of products and technologies. It achieves this by:

  • removing the need for multiple price negotiations between providers and suppliers;
  • guaranteeing automatic reimbursement by NHS England when an approved innovation is used; and
  • allowing NHS England and the Department of Health to negotiate national “bulk buy” discounts on behalf of hospitals, GPs and patients.
Implementation of ITT initiatives in the North East and North Cumbria
  • Locally, a clinical evaluation of Episcissors-60 (fixed angle scissors which take away human error in estimating episiotomy angles during childbirth and minimise the risk of obstetric and anal sphincter injury) has been commissioned from five maternity units in the region, coordinated by The Newcastle upon Tyne Hospitals NHS Trust, with a qualitative evaluation of the adoption process led by Newcastle University. The final report is due in December 2018.
  • There is growing interest in myCOPD, a web-based application for the self-management of COPD, which has been taken up by two CCGs by June 2018, with more to follow in the near future.
  • The Non-Injectable Arterial Connector (NIC), which prevents accidental injection of IV medication into arterial lines, is being piloted in a number of areas (intensive care, theatre suite and two wards) for six months commencing May 2018 at The Newcastle upon Tyne Hospitals NHS Foundation Trust.
  • The Urolift day case procedure for treatment of lower urinary tract symptoms of benign prostatic hyperplasia is provided by three Trusts in the region (City Hospitals Sunderland NHS Foundation Trust, The Newcastle upon Tyne Hospitals NHS Foundation Trust and South Tees Hospitals NHS Foundation Trust). This procedure has a distinct tariff under the Payment by Results system.
  • The Pneux for prevention of ventilation associated pneumonia in critically ill patients has yet to be taken up by any Trusts in the region.
  • Frozen Faecal Microbiota Transplantation (FMT), the provision of a screened, specially prepared stool administered via a nasal tube into the intestine to restore the balance of bacteria within the gut to treat recurrent Clostridium Difficile Infection, is expected to be available in the summer 2018 under this initiative.

Case studies for the above ITT innovations can be found in the AHSN NENC Innovation Library

ITP initiatives (announced by NHS England in April 2018)

The AHSN will be seeking opportunities for adoption across the region for:

  • Heartflow – Rapid diagnosis of patients with suspected Coronary Heart Disease (CAD) using advanced image analysis software (only for Trusts with >700 CT angiographies per annum).
  • Plus Sutures – Reduction of Surgical Site Infections (SSI) through the use of antimicrobial suture packs (only for Trusts with a greater than 4% infection rate and therefore no local trusts are eligible).
  • Endocuff – Improved colorectal examination for patients undergoing bowel cancer screening (six Trusts in the region were involved in the clinical trial of Endocuff Vision).
  • SecurAcath – Improved stability and reduced infection risk for patients with a peripherally inserted catheter.